3',6'-二(BETA-D-吡喃葡萄糖基氧基)螺[异苯并呋喃-1(3H),9'-[9H]氧杂蒽]-3-酮 | 129787-66-2

• 分子结构分类: 有机化合物 - 有机氧化合物
• 中文名称: 3',6'-二(BETA-D-吡喃葡萄糖基氧基)螺[异苯并呋喃-1(3H),9'-[9H]氧杂蒽]-3-酮
• 中文别名: 荧光素-二-β-D-吡喃葡萄糖苷；荧光素 二-Β-D-吡喃葡萄糖苷
• 英文名称: FDGlu
• 英文别名: 3',6'-bis[[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy]spiro[2-benzofuran-3,9'-xanthene]-1-one
• CAS: 129787-66-2
• 化学式: C₃₂H₃₂O₁₅
• 分子量: 656.6
• InChiKey: ZTOBILYWTYHOJB-LWXMCBIJSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  -0.2
• 重原子数：
  47
• 可旋转键数：
  6
• 环数：
  7.0
• sp3杂化的碳原子比例：
  0.41
• 拓扑面积：
  234
• 氢给体数：
  8
• 氢受体数：
  15

文献信息

• [EN] PYRROLOPYRIDINE DERIVATIVES<br/>[FR] DERIVES DE PYRROLOPYRIDINE
  申请人：GLAXO GROUP LTD

  公开号：WO2005121140A1

  公开（公告）日：2005-12-22

  The present invention relates to novel pyrrolopyridine derivatives, pharmaceutical compositions containing these compounds and their use in the treatment of diseases, particularly pain, which diseases are caused directly or indirectly by an increase or decrease in activity of the cannabinoid receptor.

  这项发明涉及新型吡咯吡啶衍生物，含有这些化合物的药物组合物以及它们在治疗疾病，特别是疼痛方面的用途，这些疾病直接或间接地由大麻素受体活性的增加或减少引起。
• [EN] PYRIDINE DERIVATIVES AND THEIR USE AS CB2 RECEPTOR MODULATORS<br/>[FR] DERIVES DE PYRIDINE ET LEUR UTILISATION EN TANT QUE MODULATEURS DU RECEPTEUR CB2
  申请人：GLAXO GROUP LTD

  公开号：WO2005080342A1

  公开（公告）日：2005-09-01

  The present invention relates to novel pyridine derivatives such as compounds of the formula (I) and the use of such compounds or pharmaceutical compositions thereof in the treatment of diseases, particularly pain, which are mediated by the activity of the cannabinoid 2 receptor.

  本发明涉及新型吡啶衍生物，如式(I)化合物以及在治疗疾病，特别是通过大麻素2受体活性介导的疼痛方面使用这些化合物或其药物组合物。
• [EN] PYRIDINE DERIVATIVES AS CONNABINOID RECEPTOR MODULATORS<br/>[FR] DERIVES DE LA PYRIDINE UTILISES COMME MODULATEURS DU RECEPTEUR CANNABINOIDE
  申请人：GLAXO GROUP LTD

  公开号：WO2005075464A1

  公开（公告）日：2005-08-18

  The present invention relates to novel pyridine derivatives such as compounds of the formula (I): and the use of such compounds or pharmaceutical compositions thereof in the treatment of diseases, particularly pain, which are mediated by the activity of the cannabinoid 2 receptor.

  本发明涉及新颖的吡啶衍生物，如式(I)的化合物，以及这些化合物或其药物组合物在治疗疾病中的应用，特别是通过大麻素2受体活性介导的疼痛。
• [EN] PYRIMIDINE DERIVATIVES AND THEIR USE AS CB2 MODULATORS<br/>[FR] DERIVES DE PYRIMIDINE ET LEUR UTILISATION EN TANT QUE MODULATEURS CB2
  申请人：GLAXO GROUP LTD

  公开号：WO2004018433A1

  公开（公告）日：2004-03-04

  This relates to novel pyrimidine derivatives, pharmaceutical compositions containing these compounds and their use in the treatment of diseases, particularly pain, which diseases are caused directly or indirectly by an increase or decrease in activity of the cannabinoid receptor.

  这涉及到新型嘧啶衍生物，含有这些化合物的制药组合物，以及它们在治疗疾病中的应用，特别是疼痛，这些疾病直接或间接地由大麻素受体活性的增加或减少引起。
• [EN] 2- (PHENYLAMINO) -PYRIMIDIN-5-AMIDES AS CANNABINOID 2 RECEPTORS MODULATORS FOR THE TREATMENT OF IMMUNE OR INFLAMMATORY DISORDERS<br/>[FR] 2-(PHENYLAMINO)-PYRIMIDIN-5-AMIDES UTILISES COMME MODULATEURS DES RECEPTEURS CANNABINOIDES 2 DANS LE TRAITEMENT DE TROUBLES IMMUNS OU INFLAMMATOIRES
  申请人：GLAXO GROUP LTD

  公开号：WO2005075440A1

  公开（公告）日：2005-08-18

  The present invention relates to novel pyrimidine derivatives such as compounds of formula (I), and the use of such compounds or pharmaceutical compositions thereof in the treatment of diseases, particularly pain, which are mediated by the activity of the cannabinoid 2 receptor.

  本发明涉及新型嘧啶衍生物，如式(I)化合物，以及利用这些化合物或其药物组合物在治疗疾病中的应用，尤其是通过大麻素2受体活性介导的疼痛。